#cellandgenetherapy
BSGCT is at ESGCT 2026 in Hamburg from 27 to 30 October! Come say hi at the BSGCT stand and chat to Ouidad Khechaoui, Emily Bates and the team to learn more about Society membership, grants, awards, mentoring schemes and more.

#ESGCT2026 #BSGCT #CellAndGeneTherapy #Hamburg
October 28, 2026 at 4:24 PM
🧐 Take a look at this #ReviewPaper:

🔋Mitochondrial Dysfunction: The Silent Catalyst of Kidney Disease Progression

🔓 Full paper: www.mdpi.com/2073-4409/14...

#Mitochondria #KidneyDisease #Mitophagy #AKI #CKD #CAKUT #CellAndGeneTherapy #RenalPathology
October 15, 2026 at 9:13 PM
We had our stars on stage, Manavi Jain and Lukas Theo Schmitt, at ZUGEHÖRT! – the Citizens' Forum on Cell and Gene Therapies by SaxoCell Cluster – on Oct 7 at Deutsches Hygiene-Museum! 👏 So good to make science accessible to the public! #CellAndGeneTherapy #ScienceForAll / #WissenschaftVermittelt
October 9, 2026 at 7:10 AM
Airport handling and visibility emerge as CAR-T logistics gaps

Pharma leaders call for better airport handling, real-time tracking and accountability to protect time-sensitive CAR-T shipments.

#carttherapy #pharmalogistics #cellandgenetherapy #coldchain #immunoact #gpls2026
Airport handling and visibility emerge as CAR-T logistics gaps
Pharma leaders call for better airport handling, real-time tracking and accountability to protect time-sensitive CAR-T shipments.
www.stattimes.com
October 9, 2026 at 12:48 PM
India’s CAR-T therapy reports no logistics-related failures across 1,000 patients, but shipment visibility, airport handling and accountability remain key challenges for global expansion.

#carttherapy #pharmalogistics #cellandgenetherapy #coldchain #immunoact #immuneeltherapeutics
Inside a CAR-T shipment: How India moves a medicine that makes a round trip
India’s CAR-T therapy reports no logistics-related failures across 1,000 patients, but shipment visibility, airport handling and accountability remain key challenges for global expansion.
www.itln.in
October 9, 2026 at 12:35 PM
#URBAGEN also highlights a broader challenge: how do we develop therapies for diseases affecting only a few hundred people worldwide? Read the full article and meet Duško Lainšček at #CTGCTDay2026 to continue the discussion.

#CellAndGeneTherapy #AdvancedTherapies
October 6, 2026 at 1:52 PM
@genethonfr.bsky.social is registered to attend
@alliancerm.bsky.social
#CGMesa26!

Can't wait to dive into discussions, network with industry leaders, and explore the latest advancements in #cellandgenetherapy.

Let the countdown begin!
See you in Phoenix! 🌵🧬

#GeneTherapy #ClinicalTrial
September 25, 2026 at 9:11 AM
Discover more about the consortium here ➡️ loom.ly/jyh6aLo

#CatapultNetwork #CellAndGeneTherapy #LifeSciences #Innovation
March 23, 2026 at 11:24 AM
🧬 @cgtcatapult.bsky.social is enabling the #CellAndGeneTherapy industry to adopt AI-powered automation, digital twins, and data integration through its Digital and Automation Testbeds.

🔗 loom.ly/NoSlHVg
August 27, 2025 at 9:19 AM
Helping to redefine #CellAndGeneTherapy, the company's breakthrough RNA platform enables controllable and long lasting delivery of genetic cargo at bioreactor scale, with no genomic integration.
August 7, 2025 at 9:01 AM
How can we bridge academia and industry to advance #CellAndGeneTherapy? 🔬

Last month, @cgtcatapult.bsky.social’s Dan Gibson & @ucl.ac.uk’s Qasim Rafiq explored the challenges & opportunities in scaling advanced manufacturing.

Watch the fireside chat 🔥 loom.ly/g0xTB_o
June 23, 2025 at 9:01 AM
#Biopharmaceutical manufacturing starts with science.

Build #biotech capability where it matters.

Explore our Biotechnology for Biopharmaceutical Manufacturing suite at: www.skillpad.com

#BiotechManufacturing #GMPTraining #Biologics #CellAndGeneTherapy #elearning #training
March 4, 2026 at 10:44 AM
☀️ VectorBuilder is at the #BMES2025 Annual Meeting, and we can’t wait to connect with the biomedical engineering community!

📍 Booth 224 | 📅 October 8-12

Stop by and say hello to our team!

#BMES2025 #VectorBuilder #BiomedicalEngineering #GeneTherapy #BiotechEvents #CellAndGeneTherapy
October 8, 2025 at 5:42 PM
VectorBuilder is honored to be recognized at the 2025 IMAPAC Biopharma Awards for leadership in gene therapy & CDMO innovation!

🏆 Best Cell & Gene Therapy Supplier Award – AAV Vector Manufacturing
🏆 Best Gene Therapy CDMO – Asia-Pacific

Proud to keep advancing global #CellandGeneTherapy progress.
September 30, 2025 at 6:28 PM
🔬 VectorBuilder is at #ASGCT2025!

Visit us at Booth 1414 from May 14–16 to explore how our custom vector design and integrated CDMO services are accelerating the development of next-generation gene therapies.

#GeneTherapy #CDMO #GMPManufacturing #VectorDesign #CellAndGeneTherapy
May 13, 2025 at 10:50 PM
Check out our Head of CDMO Global Operations Alan Griffith PhD discuss how vectors are the unsung heroes of cell and gene therapy in a new episode of Transformation in Trials!

📽 YouTube: www.youtube.com/watch?v=BgXF...

#cellandgenetherapy #cdmo #gmp #breakthroughtherapy #lifesciences #podcast
From Lab to Patient: Why Vector Design Makes or Breaks Cell Therapies with Alan Griffith
YouTube video by Transformation in Trials
www.youtube.com
March 26, 2025 at 3:09 PM